Up a level |
Goebel, Andreas ORCID: 0000-0002-3763-8206, Andersson, David, Barker, Chris, Basu, Neil, Bullock, Craig, Bevan, Stuart, Bashford-Rogers, Rachael JM, Choy, Ernest, Clauw, David, Dulake, Debra et al (show 19 more authors)
(2022)
Research Recommendations Following the Discovery of Pain Sensitizing IgG Autoantibodies in Fibromyalgia Syndrome.
PAIN MEDICINE, 23 (6).
pp. 1084-1094.
Humby, Frances, Durez, Patrick, Buch, Maya H, Lewis, Myles J, Rizvi, Hasan, Rivellese, Felice, Nerviani, Alessandra, Giorli, Giovanni, Mahto, Arti, Montecucco, Carlomaurizio et al (show 20 more authors)
(2021)
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
LANCET, 397 (10271).
pp. 305-317.